Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Maret initiates clinical development of MARstem for chemotherapy-induced neutropenia

Dec. 3, 1999

Foscan NDA accepted for review

Dec. 3, 1999

Liposomal vinorelbine: design and preliminary characterization in vitro and in vivo

Dec. 1, 1999

Eukarion awarded SBIR grant to develop treatment for radiation damage

Dec. 1, 1999

MMP inhibitor NF-681 targets renal cell carcinoma

Dec. 1, 1999

Team from P&G discovers new use for an old drug

Dec. 1, 1999

Efficacy of FXR-targeting therapy validated by Symphar-Ilex team

Dec. 1, 1999

3-DP investigators study role of MMP in tumor angiogenesis

Nov. 30, 1999

Sindan and Pfizer team up to develop new multitargeted antifolate

Nov. 30, 1999

Ligand applies for E.U. marketing approval of Targretin as CTCL therapy

Nov. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.